Michigan Taps Orchid Cellmark for Paternity Testing | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orchid Cellmark will provide its DNA paternity testing services to the State of Michigan under a new contract valued at around $5.2 million, the company said today.

The firm said that the contract enables it to provide its services to the Michigan Department of Human Services' Office of Child Support and the Children's Protective Services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.